Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s Why

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $15.40, but opened at $14.5595. Ono Pharmaceutical shares last traded at $14.5595, with a volume of 7,522 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock presently has an average rating of “Strong Buy”.

Ono Pharmaceutical Trading Down 5.5%

The firm has a market capitalization of $6.84 billion, a PE ratio of 13.87 and a beta of 0.33. The company has a fifty day moving average of $14.63 and a 200-day moving average of $14.82. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.02 and a quick ratio of 2.56.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research?based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.